BioCardia, Inc. | Business Contracts

Form of Securities Purchase and Registration Rights Agreement, dated December 14, 2022, by and among the Company and the Investors (Filed With SEC on December 15, 2022)

Controlled Equity Offering Sales Agreement, dated April 12, 2022, by and between BioCardia, Inc. and Cantor Fitzgerald & Co (Filed With SEC on April 12, 2022)

Lease agreement, dated December 14, 2021 between the Company and the Irvine Company LLC (Filed With SEC on March 29, 2022)

Consulting Agreement dated February 15, 2021, by and between BioCardia, Inc. and Henricus Duckers, M.D., Ph.D., FESC (Filed With SEC on May 13, 2021)

Note dated May 1, 2020, between BioCardia Lifesciences, Inc. and Silicon Valley Bank (Filed With SEC on May 8, 2020)

Settlement Agreement and Mutual Release, dated March 11, 2022 by and between the Company and BSLF, LLC (Filed With SEC on March 29, 2022)

Consulting Agreement dated February 15, 2021, between the Company and Henricus Duckers, M.D., Ph.D., FESC (Filed With SEC on March 30, 2021)

BioCardia 2016 Equity Incentive Plan, as amended (Filed With SEC on March 30, 2021)

Registration Rights Agreement, dated as of March 29, 2021, by and between BioCardia, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 29, 2021)

Purchase Agreement, dated as of March 29, 2021, by and between BioCardia, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 29, 2021)

Securities Purchase Agreement dated December 15, 2020, by and among BioCardia, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on December 16, 2020)

Placement Agency Agreement dated December 15, 2020, between BioCardia, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on December 16, 2020)

Securities Purchase Agreement dated December 14, 2020, by and among BioCardia, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on December 15, 2020)

Placement Agency Agreement dated December 14, 2020, between BioCardia, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on December 15, 2020)

Underwriting Agreement, dated June 17, 2020, with A.G.P./Alliance Global Partners, as representative of the several underwriters (Filed With SEC on June 19, 2020)

Form of Pre-Funded Warrant (Filed With SEC on June 15, 2020)

Form of Underwriting Agreement (Filed With SEC on June 15, 2020)

Form of Director Restricted Stock Unit Agreement under the BioCardia 2016 Equity Incentive Plan (Filed With SEC on May 15, 2020)

Litigation Funding Agreement dated April 9, 2020, between BSLF, L.L.C. and BioCardia, Inc (Filed With SEC on April 14, 2020)

Description of Registered Securities (Filed With SEC on April 9, 2020)

Form of Representatives Warrant (Filed With SEC on August 7, 2019)

Form of Common Stock Purchase Warrant (Filed With SEC on August 7, 2019)

Form of Warrant Agreement (Filed With SEC on August 1, 2019)

Form of Common Stock Purchase Warrant (Filed With SEC on August 1, 2019)

Form of Warrant Agreement (Filed With SEC on July 23, 2019)

Form of Representatives Warrant (Filed With SEC on July 23, 2019)

Form of Common Stock Purchase Warrant (Filed With SEC on July 23, 2019)

Form of Underwriting Agreement (Filed With SEC on July 23, 2019)

Note Purchase Agreement dated July 5, 2019 (Filed With SEC on July 5, 2019)

Form of Convertible Promissory Note (Filed With SEC on July 5, 2019)

BioCardia, Inc. (30)